STARNA THERAPEUTICS
Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
STARNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2021-08-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.starnatx.com
Total Employee:
11+
Status:
Active
Contact:
0512-6516 5336
Email Addresses:
[email protected]
Total Funding:
32.1 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF WordPress SSL By Default Mobile Non Scaleable Content HSTS Nginx Wordpress Plugins
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Sonoma BioTherapeutics
Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Investors List
Hillhouse Investment
Hillhouse Investment investment in Series A - Starna Therapeutics
LYFE Capital
LYFE Capital investment in Series A - Starna Therapeutics
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Series A - Starna Therapeutics
Hony Capital
Hony Capital investment in Series A - Starna Therapeutics
Source Code Capital
Source Code Capital investment in Series A - Starna Therapeutics
Primavera Capital Group
Primavera Capital Group investment in Series A - Starna Therapeutics
GL Ventures LLC
GL Ventures LLC investment in Angel Round - Starna Therapeutics
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Angel Round - Starna Therapeutics
More informations about "Starna Therapeutics"
About | 星锐医药 - starnatx.com
星锐医药(Starna Therapeutics) 成立于2021年8月，公司聚焦肝外靶向递送技术，致力于研发以RNA为核心的创新药物，解决未被满足的临床需求。See details»
About-En | 星锐医药 - starnatx.com
Contact us. China: 2F, Building 2, 99 Jingu Road, Suzhou, 215123 US: 329 Oyster Point Blvd, South San Francisco, CA 94080See details»
Starna Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 0512-6516 5336 Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and …See details»
Starna Therapeutics - Products, Competitors, Financials, Employees ...
Starnatx.com. Overview & Products; Financials; People; Founded Year 2021. Stage Series A - II | Alive. Total Raised $32.1M. Last Raised $22.1M | 3 yrs ago. About Starna Therapeutics. …See details»
Starna therapeutics (星锐医药（苏州）有限公司) - 药物管线_专利_ …
了解Starna therapeutics (星锐医药（苏州）有限公司)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 105篇新闻，疾病领域:感染，技术平台:预防性疫苗，基因编辑，mRNA疫 …See details»
星锐医药 - 公司详情 - 公司概况 - innoHere英诺嘿呀
星锐医药创立于2021年8月，由国内外在递送技术与核酸治疗领域拥有丰富产业技术与管理经验的人才组建。公司已建立拥有自主知识产权的mrna设计合成及lnp递送技术平台，实现组织特异 …See details»
星锐医药 | 项目信息-36氪
星锐医药公司创立于2021年8月，以“服务生命健康”为使命，致力于研发rna为核心的创新药物，以解决未被满足的临床需求，研发管线涵盖了传染病疫苗、肿瘤免疫、代谢疾病等领域。See details»
星锐医药 - starnatx.com
Contact us. China: 2F, Building 2, 99 Jingu Road, Suzhou, 215123 US: 329 Oyster Point Blvd, South San Francisco, CA 94080See details»
Starna Therapeutics - LinkedIn
Delighted to share our latest findings on the mRNA-based RSV preF vaccine (STR-V003). In this research, we have developed a novel muscle-targeted LNP featuring a newly engineered preF …See details»
Starna Therapeutics 2025 Company Profile: Valuation, Funding ...
Starna Therapeutics General Information Description. Developer of RNA innovative drugs. The company is committed to research and development of innovative drugs as the core RNA to …See details»
星锐医药-动脉网 - vbdata.cn
Dec 13, 2021 [email protected] 星锐医药（苏州）有限公司创立于2021年8月，以“服务生命健康”为使命，致力于研发RNA为核心的创新药物，以解决未被满足的临床需求，研发管线涵盖 …See details»
Sherpa Friends | 夏尔巴投资企业星锐医药呼吸道合胞病毒RSV …
点击蓝字 关注我们. 2024年3月8日，夏尔巴投资企业星锐医药（Starna Therapeutics），一家聚焦靶向递送技术及创新mRNA疗法的生物技术公司，宣布其自主研发及生产的呼吸道合胞病 …See details»
星锐医药
星锐医药(Starna Therapeutics) 成立于2021年8月，公司聚焦肝外靶向递送技术，致力于研发以RNA为核心的创新药物，解决未被满足的临床需求。See details»
星锐医药-星锐医药(苏州)有限公司-企业详情-InvestGO数据库-ByDr…
查看医药魔方InvestGO®数据库星锐医药的公司信息。星锐医药（星锐医药(苏州)有限公司），公司简介：星锐医药公司创立于2021年8月，以“服务生命健康”为使命，致力于研发RNA为核心 …See details»
Starna therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Www.starnatx.com. Private Company | 2021 | Jiangsu Sheng, China | www.starnatx.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»
星锐医药 - 公司详情 - 资讯 - innoHere英诺嘿呀
星锐医药创立于2021年8月，由国内外在递送技术与核酸治疗领域拥有丰富产业技术与管理经验的人才组建。公司已建立拥有自主知识产权的mrna设计合成及lnp递送技术平台，实现组织特异 …See details»
Platform-En | 星锐医药 - starnatx.com
The utilization of mRNA in COVID-19 vaccines during the pandemic has validated its immense potential and clinical safety, as billions of doses have been administered.See details»
战略合作| 时夕生物与星锐医药联合推进RNA编辑疗法医药新闻 …
Jun 12, 2024 公司先后获得多家知名基金参与的数亿元融资，已在mRNA疫苗和创新疗法布局丰富的研发管线，其中呼吸道合胞病毒mRNA疫苗STR-V003已获得FDA临床试验许可，预计 …See details»
The Home of Elon Musk's SpaceX Could Become an Official Texas …
13 hours ago Hinojosa said her organization tried to organize a block walk around SpaceX to encourage voters to reject the city vote. The company’s private security escorted them away, …See details»
The home of Elon Musk's SpaceX could become an official Texas …
13 hours ago The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»